MENU
+Compare
BWAY
Stock ticker: NASDAQ
AS OF
Jan 8 closing price
Price
$9.62
Change
-$0.10 (-1.03%)
Capitalization
86.77M

BWAY BrainsWay Ltd Forecast, Technical & Fundamental Analysis

a developer and manufacturer of deep transcranial magnetic stimluation systems, novel, noninvasive medical devices

BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BWAY with price predictions
Jan 08, 2025

BWAY's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BWAY turned positive on January 02, 2025. Looking at past instances where BWAY's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BWAY's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 02, 2025. You may want to consider a long position or call options on BWAY as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BWAY advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

BWAY moved below its 50-day moving average on December 11, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BWAY crossed bearishly below the 50-day moving average on December 18, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BWAY broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BWAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.205) is normal, around the industry mean (23.369). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.874) is also within normal values, averaging (41.065).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BWAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
BWAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BWAY is expected to report earnings to 1 cents per share on April 01

BrainsWay Ltd BWAY Stock Earnings Reports
Q4'24
Est.
$0.02
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.01
The last earnings report on November 12 showed earnings per share of 1 cents, beating the estimate of 0 cents. With 29.10K shares outstanding, the current market capitalization sits at 86.77M.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of deep transcranial magnetic stimluation systems, novel, noninvasive medical devices

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
19 Hartum Street
Phone
+972 25824030
Employees
134
Web
https://www.brainsway.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANDE42.210.57
+1.37%
Andersons
V312.600.93
+0.30%
VISA
HAS57.11N/A
N/A
Hasbro
JOUT34.36-0.62
-1.77%
Johnson Outdoors
EPIX1.82-0.07
-3.70%
ESSA Pharma

BWAY and Stocks

Correlation & Price change

A.I.dvisor tells us that BWAY and DXR have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BWAY and DXR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BWAY
1D Price
Change %
BWAY100%
-1.03%
DXR - BWAY
27%
Poorly correlated
-1.36%
SINT - BWAY
26%
Poorly correlated
-7.53%
RGEN - BWAY
23%
Poorly correlated
+0.78%
BVS - BWAY
22%
Poorly correlated
+0.31%
ANIK - BWAY
22%
Poorly correlated
+1.53%
More